Andersen Group, Inc. (ANDG) is a global professional services firm providing tax, consulting, legal, valuation, and advisory services. It went public in December 2025 and has since drawn coverage from a broad set of banks.
Across eight analysts tracked by S&P Global, the overall average price target is $61.29, with a range of roughly $49 to $78 and a consensus rating of Buy. Because that average sits below the recent share price, a simple mean would not provide a meaningful forward-looking objective. The two verified targets that are actually above the current price — $78 from UBS (Buy, November 2026) and $70 from Truist Securities (Buy, September 2026) — average to $74, which is the central target used here. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The spread in analyst price targets is unusually wide, reflecting disagreement about how to value a fast-growing but newly listed company. Bullish firms such as UBS and Truist emphasize durable organic growth, margin expansion, and a large acquisition pipeline. More cautious firms — including BMO Capital's Market Perform rating with a $58 target — point to valuation and to GAAP earnings that remain pressured by stock-based compensation and tax effects. Baird ($64, Outperform) and Deutsche Bank ($56, Buy) sit between the two poles.
The stock closed near $65.77, so a move to $74 implies upside of about 12%. That is a modest required advance, but it would still take the shares into territory above every analyst target except UBS's $78, and near the top of the 52-week range of roughly $18 to $68.
The path toward the target likely depends on whether Andersen can sustain the growth that has driven a dramatic re-rating since its IPO. Third-quarter 2026 revenue rose 18.7% year over year to $337.3 million, with nine-month revenue up 19.1% to $795.7 million. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 18.8% to $154.5 million, holding a 45.8% margin. Management also introduced 2027 revenue guidance of $1.275 billion to $1.325 billion, well above the roughly $1 billion expected for 2026.
The shares have climbed from a 52-week low near $18 to a high around $68, placing the stock in a strong long-term uptrend but also near potential resistance. A move toward $74 would require clearing the $70 area — a level coinciding with Truist's target — followed by the psychological $75 level, with UBS's $78 marking the next reference point. On the downside, the $58–$64 zone contains several analyst targets and could act as an area of support if momentum stalls.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms do not always disclose a precise time frame. Investors should watch quarterly revenue and organic growth, the pace and integration of announced acquisitions, GAAP versus adjusted profitability trends, and any changes to 2027 guidance. Analyst revisions — especially whether cautious firms raise their targets toward the $70–$78 band — will be a key signal of whether the modest gap to $74 is closing.
In my own research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to get a dynamic, AI-driven perspective on stocks like this one. The tool continuously scans market conditions and technical patterns to generate Buy, Sell, or Hold signals, which helps me cross-check fundamental views with real-time data without replacing core analysis.
The $74 central target is not a consensus forecast but the average of the two analyst targets that sit above the current price — a reflection of how far this newly listed stock has already run. Reaching it would require a modest 12% advance into largely uncharted territory. Support comes from strong revenue growth, stable margins, and an aggressive acquisition strategy, while the principal obstacles are GAAP earnings pressure, a demanding valuation, and a sell-side community whose average target remains below the current quote. The clearest signals to monitor are execution on the 2027 guidance and whether more analysts begin raising their targets into the $70–$78 range.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ANDG broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 7 similar instances where the stock broke above the upper band. In 5 of the 7 cases the stock fell afterwards. This puts the odds of success at 71%.
The 10-day RSI Indicator for ANDG moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In 3 of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 4 of 10 cases where ANDG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 40%.
The Moving Average Convergence Divergence Histogram (MACD) for ANDG turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 2 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 29%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANDG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
Following a +1.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANDG advanced for three days, in 44 of 48 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 70 of 74 cases where ANDG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ANDG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.554) is normal, around the industry mean (8.051). P/E Ratio (17.263) is within average values for comparable stocks, (10.423). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.440). Dividend Yield (0.000) settles around the average of (0.081) among similar stocks. ANDG's P/S Ratio (6.803) is very high in comparison to the industry average of (1.645).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANDG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PersonnelServices